Public Contracts Scotland

NP48925d Hereditary Angioedema Branded Medicines (Cinryze and Takhzyro)

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Awarded
supplies
Scotland
Price only

This tender has closed

The submission deadline for this contract has passed. There may be more active supplies tenders from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS), and hundreds more across the UK public sector.

Key details

Region
Edinburgh
Contract value
£9,461,556ex VAT
Submissions closed
Not stated by buyer
Published
1 May 2025

Procurement

Procedure type
Award procedure without prior publication of a call for competition
CPV classifications
  • 33600000 Pharmaceutical products

What happened

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) awarded this contract to Takeda UK Limited worth £9,461,556 on 4 Apr 2025.

Description

Supply of Hereditary Angioedema Branded Medicines (Cinryze® and Takhzyro®) to NHS Scotland.

Full description

The Framework Agreement is for the supply of several hereditary angioedema (HAE) branded medicines to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

Additional information

The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. Details of individual lines awarded can be requested from the named person at the head of this notice.

Awarded supplier

Supplier
Takeda UK Limited
Award value
£9,461,556
Award date
4 April 2025

Contact

Address
1 South Gyle Crescent, Edinburgh, EH12 9EB
Contact name
Cameron Wright

Identifiers

Notice ID
rls-82-MAY529529
OCID
ocds-r6ebe6-0000794852

Explore related tenders

Other tenders from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

View all →

External ID: pcs-ocds-r6ebe6-0000794852 • Added 27 May 2026